Format

Send to:

Choose Destination
See comment in PubMed Commons below
BMC Surg. 2001;1:1. Epub 2001 May 16.

Percutaneous treatment of chronic MRSA osteomyelitis with a novel plant-derived antiseptic.

Author information

  • 1OR Design Unit, University of Sydney, Nepean Hospital, PO Box 63, Penrith, NSW 2750, Australia. esherry@bigpond.com

Abstract

BACKGROUND:

Antibiotic-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococcus (VRE, are an increasing problem world-wide, causing intractable wound infections. Complex phytochemical extracts such as tea tree oil and eucalypt-derived formulations have been shown to have strong bactericidal activity against MRSA in vitro. Polytoxinol (PT) antimicrobial, is the trade name of a range of antimicrobial preparations in solution, ointment and cream form.

METHODS:

We report the first use of this drug, administered percutaneously, via calcium sulphate pellets (Osteoset,TM), into bone, to treat an intractable MRSA infection of the lower tibia in an adult male.

RESULTS AND DISCUSSION:

Over a three month period his symptoms resolved with a healing response on x-ray and with a reduced CRP.

PMID:
11368798
[PubMed - indexed for MEDLINE]
PMCID:
PMC32179
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for BioMed Central Icon for PubMed Central
    Loading ...
    Write to the Help Desk